Quick Answer
PDS Biotechnology Corp reported Earnings Per Share Diluted of $0.74 (loss) per share for the year ending 2025.
- PDS Biotechnology Corp showed an increase of +28.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from PDS Biotechnology Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), PDS Biotechnology Corp's Earnings Per Share Diluted has grown by 16.9%.
- Historical annual values: Fiscal year 2025: $0.74 (loss) per share | Fiscal year 2024: $1.03 (loss) per share | Fiscal year 2023: $1.39 (loss) per share | Fiscal year 2022: $1.43 (loss) per share | Fiscal year 2021: $0.66 (loss) per share | Fiscal year 2020: $0.89 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: